Adalat LA 30mg tablets

국가: 영국

언어: 영어

출처: MHRA (Medicines & Healthcare Products Regulatory Agency)

유효 성분:

Nifedipine

제공처:

Bayer Plc

ATC 코드:

C08CA05

INN (국제 이름):

Nifedipine

복용량:

30mg

약제 형태:

Modified-release tablet

관리 경로:

Oral

수업:

No Controlled Drug Status

처방전 유형:

Caution - AMP level prescribing advised

제품 요약:

BNF: 02060200; GTIN: 5010605005107

환자 정보 전단

Page 1 of 2
PACKAGE LEAFLET: INFORMATION FOR THE USER
ADALAT
®
LA 30MG TABLETS
(nifedipine)
Your medicine is available using the name Adalat LA 30mg
Tablets, but will be referred to as Adalat LA throughout this
leaflet.
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU
START TAKING THIS MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor or
pharmacist.

This medicine has been prescribed for you only. Do not
pass it on to others. It may harm them, even if their
signs of illness are the same as yours.

If you get any side effects, talk to your doctor or
pharmacist. This includes any possible side effects not
listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Adalat LA is and what it is used for
2.
What you need to know before you take Adalat LA
3.
How to take Adalat LA
4.
Possible side effects
5.
How to store Adalat LA
6.
Contents of the pack and other information
1.
WHAT ADALAT LA IS AND WHAT IT IS USED FOR
Adalat LA contains nifedipine, which belongs to a group of
medicines called _calcium antagonists. _
ADALAT LA IS USED TO TREAT HIGH BLOOD PRESSURE OR ANGINA
_(chest pain)_.
For high blood pressure: Adalat LA works by relaxing and
expanding the blood vessels. This makes the blood flow more
easily and lowers blood pressure. Lower blood pressure
reduces the strain on your heart.
For angina: Adalat LA works by relaxing and expanding the
arteries supplying the heart. This allows more blood and
oxygen to reach the heart and decreases the strain on it. Your
angina attacks will be less severe and less frequent if there is
less strain on the heart.
2.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE
ADALAT LA
DO NOT TAKE ADALAT LA:

IF YOU HAVE HAD A HEART ATTACK within the last month.

IF YOU GET A SUDDEN ANGINA ATTACK. Adalat LA will not
help relieve symptoms of angina quickly.

IF YOU HAVE UNSTABLE ANGINA.

IF YOU ARE ALLERGIC to nifedipine, any other similar
medicines (known as

제품 특성 요약

OBJECT 1
ADALAT LA 30 MG PROLONGED-RELEASE TABLETS
Summary of Product Characteristics Updated 12-Oct-2017 | Bayer plc
1. Name of the medicinal product
Adalat LA 30 mg prolonged-release tablets
2. Qualitative and quantitative composition
Each prolonged-release tablet contains 30 mg nifedipine.
Each tablet contains a 10% overage of nifedipine to deliver the label
claim.
For the full list of excipients, see section 6.1.
3. Pharmaceutical form
Prolonged-release tablet.
Pink, round, convex prolonged-release tablet with a laser hole on one
side and marked with Adalat 30.
4. Clinical particulars
4.1 Therapeutic indications
For the treatment of all grades of hypertension.
For the prophylaxis of chronic stable angina pectoris either as
monotherapy or in combination with a
beta-blocker.
4.2 Posology and method of administration
_Posology_
In mild to moderate hypertension, the recommended initial dose is one
20 mg tablet once-daily. In severe
hypertension, the recommended initial dose is one 30 mg tablet
once-daily. If necessary, the dosage can
be increased according to individual requirements up to a maximum of
90 mg once-daily.
For the prophylaxis of angina pectoris, the recommended initial dose
is one 30 mg tablet once-daily. The
dosage can be increased according to individual requirements up to a
maximum of 90 mg once-daily.
Patients in whom hypertension or anginal symptoms are controlled on
Adalat capsules or Adalat retard
may be safely switched to Adalat LA. Prophylactic anti-anginal
efficacy is maintained when patients are
switched from other calcium antagonists such as diltiazem or verapamil
to Adalat LA. Patients switched
from other calcium antagonists should initiate therapy at the
recommended initial dose of 30 mg Adalat
LA once-daily. Subsequent titration to a higher dose may be initiated
as warranted clinically.
Co-administration with CYP 3A4 inhibitors or CYP 3A4 inducers may
result in the recommendation to
adapt the nifedipine dose or not to use nifedipine at all (see section
4.5).
_Duration of treatment_
Tre